Drug General Information
Drug ID
D03CMZ
Drug Name
CAR-T cells targeting EGFRviii
Drug Type
CAR T Cell Therapy
Indication Glioblastoma multiforme [ICD-11: 2A00.0; ICD-9: 191] Phase 1 [1]
Company
Shenzhen Geno-Immune Medical Institute
Target and Pathway
Target(s) Epidermal growth factor receptor variant III (EGFR vIII) Target Info CAR-T-Cell-Therapy [1]
References
REF 1 ClinicalTrials.gov (NCT03170141) Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Wang and Dr. Li.